A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs
Clinical trial NCT00364026 · COMPLETED
Trial details
- NCT number
- NCT00364026
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.